Shenzhen JYMed Technology Co., Ltd.

Founded in 2009, Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. (hereinafter referred to as: Jianyuan pharmaceutical) is an innovative pharmaceutical enterprise with independent intellectual property rights, which integrates the research and development, production and sales of peptide drugs. The company has two wholly-owned subsidiaries, Shenzhen Jianyuan biopharmaceutical Co., Ltd. and Hubei Jianyuan biopharmaceutical Co., Ltd. The company takes the lead in establishing the R & D technology platform of known target natural product prodrugs, peptides and protein drug sustained-release preparations in China; Most of the R & D products are peptide products at home and abroad, with advanced technology in the world and leading position in China. In 2010, after Xingyin Pharmaceutical Group invested and controlled Jianyuan pharmaceutical, Jianyuan pharmaceutical entered a period of rapid development, with the registered capital increasing from 2 million to 89.5 million.

Jianyuan medicine has established a long-term cooperative relationship with many universities and scientific research institutes at home and abroad. It has a high-quality project management, research and development and marketing team and a team of experts and consultants. The company has a 1000m2 R & D center in the biological incubator of high tech Zone; The R & D center has a complete drug research and development system, equipped with advanced equipment, such as high performance liquid chromatography, preparation chromatography, mass spectrometry, gas chromatography, ion chromatography, as well as sustained-release microspheres pilot production line. At the same time, a new drug development and research platform with an area of about 5000 m2 has been built in the biological accelerator of Pingshan new area.

Jianyuan pharmaceutical company currently has two production bases. Among them, the plant in Lishui, Nanjing has built four peptide API production lines that meet the requirements of FDA, and some peptide products are exported to mainstream drug markets such as Europe and the United States; In Pingshan New District of Shenzhen, two preparation production lines have been built to meet the requirements of GMP, mainly producing cartridge injection, small volume injection and lyophilized powder injection. In addition, the company also purchased more than 300 mu of land in Hubei Xian'an Economic Development Zone to build a new peptide drug industrial production base in line with FDA, EU and Chinese GMP standards.

In recent years, Jianyuan medicine has been recognized as "Shenzhen high-tech enterprise" and "national high-tech enterprise". As always, Jianyuan people will continue to carry out scientific and technological innovation and management innovation activities through accurate market positioning and scientific marketing strategy, relying on outstanding entrepreneurs and employees. By means of information management, Jianyuan pharmaceutical has established a strict quality control system and comprehensive management to lay a good foundation for the sustainable development of the company. Adhering to the enterprise spirit of "integrity, responsibility, efficiency and cooperation", Jianyuan pharmaceutical will strive to become an influential innovative enterprise in the pharmaceutical industry, and will unremittingly provide reliable pharmaceutical products for human health!